Zobrazeno 1 - 10
of 1 278
pro vyhledávání: '"S. Baik"'
Autor:
Cameron Chalker, Jenna M. Voutsinas, Qian Vicky Wu, Rafael Santana‐Davila, Victoria Hwang, Christina S. Baik, Sylvia Lee, Brittany Barber, Neal D. Futran, Jeffrey J. Houlton, George E. Laramore, Jay Justin Liao, Upendra Parvathaneni, Renato G. Martins, Keith D. Eaton, Cristina P. Rodriguez
Publikováno v:
Cancer Medicine, Vol 11, Iss 22, Pp 4104-4111 (2022)
Abstract Background Anti‐PD1 checkpoint inhibitors (ICI) represent an established standard‐of‐care for patients with recurrent/metastatic head and neck squamous cell carcinoma (RMHNSCC). Landmark studies excluded patients with ECOG performance
Externí odkaz:
https://doaj.org/article/53da6a9d3e554131937be881d3ebe09e
Autor:
Jacqueline F. Pelham, Alexander E. Mosier, Samuel C. Altshuler, Morgan L. Rhodes, Christopher L. Kirchhoff, William B. Fall, Catherine Mann, Lisa S. Baik, Joanna C. Chiu, Jennifer M. Hurley
Publikováno v:
Cell Reports, Vol 42, Iss 4, Pp 112376- (2023)
Summary: Biology is tuned to the Earth’s diurnal cycle by the circadian clock, a transcriptional/translational negative feedback loop that regulates physiology via transcriptional activation and other post-transcriptional mechanisms. We hypothesize
Externí odkaz:
https://doaj.org/article/c80d004282bf4daf8ba96764cdb5aff1
Autor:
Bruce E. Johnson, MD, Christina S. Baik, MD, Julien Mazieres, MD, Harry J.M. Groen, MD, Barbara Melosky, MD, Jürgen Wolf, MD, Fatemeh Asad Zadeh Vosta Kolaei, PhD, Wen-Hsing Wu, MS, Stefanie Knoll, PhD, Meryem Ktiouet Dawson, MD, Adam Johns, PhD, David Planchard, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 5, Pp 100324- (2022)
Introduction: BRAF mutations are rare in patients with NSCLC, and treatment options are limited. Dabrafenib plus trametinib (dab-tram) was approved for BRAFV600-mutated advanced NSCLC (aNSCLC), based on results from a phase 2 study (NCT01336634). Thi
Externí odkaz:
https://doaj.org/article/d127605cbc444e079ca861d9fffd5178
Autor:
Stephen R. Bowen, PhD, Daniel S. Hippe, MS, Hannah M. Thomas, PhD, Balukrishna Sasidharan, MBBS, MD, DNB, DMRT, Paul D. Lampe, PhD, Christina S. Baik, MD, MPH, Keith D. Eaton, MD, PhD, Sylvia Lee, MD, Renato G. Martins, MD, MPH, Rafael Santana-Davila, MD, Delphine L. Chen, MD, Paul E. Kinahan, PhD, Robert S. Miyaoka, PhD, Hubert J. Vesselle, MD, PhD, A. McGarry Houghton, MD, Ramesh Rengan, MD, PhD, Jing Zeng, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 2, Pp 100857- (2022)
Purpose: We sought to examine the prognostic value of fluorodeoxyglucose-positron emission tomography (PET) imaging during chemoradiation for unresectable non-small cell lung cancer for survival and hypothesized that tumor PET response is correlated
Externí odkaz:
https://doaj.org/article/3fb66f4cd14d4b90978539f30c9d469e
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 6, Pp 100177- (2021)
Optimal management of EGFR-mutated NSCLC with leptomeningeal (LM) disease progression through EGFR tyrosine kinase inhibitor remains unclear. We present a 39-year-old man with EGFR-mutated NSCLC and LM disease progression through osimertinib 80 mg da
Externí odkaz:
https://doaj.org/article/70fdfd6dfc4a45b78408294ac16dd2df
Publikováno v:
BMC Anesthesiology, Vol 18, Iss 1, Pp 1-7 (2018)
Abstract Background Microaspiration past the tracheal tube cuffs causes ventilator-associated pneumonia. The objective of the current study was to evaluate whether creating negative pressure between the tracheal double cuffs could block the fluid pas
Externí odkaz:
https://doaj.org/article/3c74da6da59f45a5ad02b7b5631317c0
Publikováno v:
Current Treatment Options in Oncology. 23:1201-1218
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a64d6ee665d71cc57a0b46d67e5c176
https://doi.org/10.1007/s11864-022-01005-8
https://doi.org/10.1007/s11864-022-01005-8
Autor:
R. Lance Holbert, Elizabeth S. Baik, Meghnaa Tallapragada, Colleen M. Tolan, Heather L. LaMarre, Bruce W. Hardy
Publikováno v:
Journal of Broadcasting & Electronic Media. 66:515-539
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f39dc523b9adfd8ca51386ad377915c8
https://doi.org/10.1080/08838151.2022.2120481
https://doi.org/10.1080/08838151.2022.2120481
Autor:
R. Lance Holbert, Elizabeth S. Baik, Meghnaa Tallapragada, Bruce W. Hardy, Colleen M. Tolan, Heather L. LaMarre
Publikováno v:
Annals of the International Communication Association. 46:231-246
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b21fb368d5ec68443d537316d0227e96
https://doi.org/10.1080/23808985.2022.2108878
https://doi.org/10.1080/23808985.2022.2108878
Autor:
Renato Martins, Keith Eaton, Laura Q.M. Chow, Christina S. Baik, Bernardo Goulart, Rafael Santana-Davila, Sylvia M. Lee, Venu G. Pillarisetty, Xiuyun Jiang, Jonathan R. Fromm, Jenna Voutsinas, Qian (Vicky) Wu, Cristina P. Rodriguez
Purpose:This clinical trial combined pembrolizumab and vorinostat in recurrent/metastatic squamous cell carcinomas of the head and neck (HN), and salivary gland cancer (SGC).Patients and Methods:Patients with progressing incurable HN and SGC, Eastern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2aacf0ad3600b9a6de56ff357102155
https://doi.org/10.1158/1078-0432.c.6529320.v1
https://doi.org/10.1158/1078-0432.c.6529320.v1
